Author:
Ashley Justin,McArthur Eric,Bota Sarah,Harel Ziv,Battistella Marissa,Molnar Amber O.,Jun Min,Badve Sunil V.,Garg Amit X.,Manuel Doug,Tanuseputro Peter,Wells Phil,Mavrakanas Thomas,Rhodes Emily,Sood Manish M.
Funder
Ontario Ministry of Health and Long-Term Care
Academic Medical Organization of Southwestern Ontario
Schulich School of Medicine and Dentistry
Western University
Lawson Health Research Institute
Canadian Institutes of Health Research
Reference43 articles.
1. Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis;Andreotti;Eur Heart J,2015
2. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation;Hylek;Circulation,2007
3. Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarin;Gasse;Thromb Haemost,2005
4. Human P450 metabolism of warfarin;Kaminsky;Pharmacol Ther,1997
5. Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation;Di Lullo;Thromb Res,2017
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献